Qlife Holding AB (OSTO:QLIFE) Shareholder Yield % : -48.07% (As of Mar. 2026)


OSTO:QLIFE Qlife Holding AB OSTO:QLIFE
15 GF Score
Price kr1.93
GF Value kr0.76
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB Shareholder Yield %?

Qlife Holding AB OSTO:QLIFE +1.47% 15 Shareholder Yield % is -48.07% as of Mar. 2026. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Qlife Holding AB ranks worse than 93.88% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Qlife Holding AB's Shareholder Yield % was -48.07%.


Qlife Holding AB  (OSTO:QLIFE) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Qlife Holding AB Shareholder Yield % Related Terms


Qlife Holding AB Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Qlife Holding AB's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qlife Holding AB Shareholder Yield % Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial -24.72 -198.66 -312.93 -39.16 -43.84

Qlife Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 2.81 9.18 -43.84 -58.44

OSTO:QLIFE vs ABT, SYK, MDT: Shareholder Yield % Comparison

For the Medical Devices subindustry, Qlife Holding AB's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB Shareholder Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Shareholder Yield % falls into.


OSTO:QLIFE
15GF Score
Qlife Holding AB OSTO:QLIFE
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qlife Holding AB Shareholder Yield % Calculation

Qlife Holding AB's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+-55.28 %+-3.16 %
=-58.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of -48.07% mean?
Qlife Holding AB (OSTO:QLIFE) has a Shareholder Yield % of -48.07% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Qlife Holding AB and its competitors. According to the industry distribution chart, Qlife Holding AB ranks #767 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 93.9%.
Is Qlife Holding AB's Shareholder Yield % too high?
Qlife Holding AB's current Shareholder Yield % is -48.07%. Based on the distribution chart, Qlife Holding AB ranks #767 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Shareholder Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #767 out of 817 companies for Shareholder Yield %. This places Qlife Holding AB in the lower half of its industry. The industry median Shareholder Yield % is 0.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.17, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Qlife Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current Shareholder Yield % is -48.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.93 — trading 153.9% above its estimated fair value. The current Shareholder Yield % is -48.07%. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Shareholder Yield % is -48.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of kr1.93 is trading 153.9% above its estimated GF Value™ of kr0.76. GuruFocus considers Qlife Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:QLIFE:

  • Shareholder Yield %: -48.07%
  • GF Value™: kr0.76 vs. price of kr1.93 (153.9% above fair value)
  • GF Score™: 15/100 with 9 warning signs

No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qlife Holding AB Business Description

Other Exchanges 4HG0:Germany
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score

Get the complete analysis for OSTO:QLIFE

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.93
Price
kr0.76
GF Value